caffeine has been researched along with Acute Kidney Failure in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "57 g of caffeine in a suicide attempt and developed rhabdomyolysis and acute renal failure." | 8.77 | Rhabdomyolysis induced by a caffeine overdose. ( Oschner, I; Wrenn, KD, 1989) |
| "To evaluate the association between caffeine exposure and acute kidney injury (AKI) in very low birth weight (VLBW; ≤1500 g) neonates." | 7.83 | Caffeine Exposure and Risk of Acute Kidney Injury in a Retrospective Cohort of Very Low Birth Weight Neonates. ( Carmody, JB; Charlton, JR; Denotti, AR; Harer, MW; Swanson, JR, 2016) |
| "Caffeine was administered for 3 days and/or PBM for 5 days following HIE." | 5.91 | Effects of photobiomodulation and caffeine treatment on acute kidney injury in a hypoxic ischemic neonatal rat model. ( Beutner, G; Brophy, PD; Dahlstrom, JE; Groves, AM; Johnston, CJ; Kent, AL; Koina, M; Marples, B; O'Reilly, M; Porter, G, 2023) |
| "Caffeine was prescribed for apnea of prematurity and caffeine exposure was determined by chart review." | 5.51 | Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation. ( Aviles-Otero, N; Carmody, JB; Green, G; Khalsa, DD; Kumar, R, 2019) |
| " Further studies should focus on the timing and dosage of caffeine to optimize the prevention of AKI." | 5.48 | Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study. ( Askenazi, DJ; Boohaker, LJ; Carmody, JB; Charlton, JR; Griffin, RL; Guillet, R; Harer, MW; Selewski, DT; Swanson, JR, 2018) |
| "Dipyridamole (DYP) is an anti-platelet agent with marked vasodilator, anti-oxidant, and anti-inflammatory activity." | 5.43 | Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats. ( Buttar, HS; Kaur, T; Mohey, V; Pathak, D; Puri, N; Singh, AP; Singh, M, 2016) |
| "57 g of caffeine in a suicide attempt and developed rhabdomyolysis and acute renal failure." | 4.77 | Rhabdomyolysis induced by a caffeine overdose. ( Oschner, I; Wrenn, KD, 1989) |
| "To evaluate the association between caffeine exposure and acute kidney injury (AKI) in very low birth weight (VLBW; ≤1500 g) neonates." | 3.83 | Caffeine Exposure and Risk of Acute Kidney Injury in a Retrospective Cohort of Very Low Birth Weight Neonates. ( Carmody, JB; Charlton, JR; Denotti, AR; Harer, MW; Swanson, JR, 2016) |
| "Caffeine was administered for 3 days and/or PBM for 5 days following HIE." | 1.91 | Effects of photobiomodulation and caffeine treatment on acute kidney injury in a hypoxic ischemic neonatal rat model. ( Beutner, G; Brophy, PD; Dahlstrom, JE; Groves, AM; Johnston, CJ; Kent, AL; Koina, M; Marples, B; O'Reilly, M; Porter, G, 2023) |
| "Caffeine was prescribed for apnea of prematurity and caffeine exposure was determined by chart review." | 1.51 | Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation. ( Aviles-Otero, N; Carmody, JB; Green, G; Khalsa, DD; Kumar, R, 2019) |
| " Further studies should focus on the timing and dosage of caffeine to optimize the prevention of AKI." | 1.48 | Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study. ( Askenazi, DJ; Boohaker, LJ; Carmody, JB; Charlton, JR; Griffin, RL; Guillet, R; Harer, MW; Selewski, DT; Swanson, JR, 2018) |
| "Dipyridamole (DYP) is an anti-platelet agent with marked vasodilator, anti-oxidant, and anti-inflammatory activity." | 1.43 | Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats. ( Buttar, HS; Kaur, T; Mohey, V; Pathak, D; Puri, N; Singh, AP; Singh, M, 2016) |
| " The disposition of TPT did not normalize in UN-ARF rats when treated with caffeine, a non-selective adenosine A1 receptor antagonist, whereas the selective adenosine A1 receptor antagonist (1,3-dipropyl-8-phenylxanthine, DPPX) normalized TPT pharmacokinetic disposition by improving renal function." | 1.33 | Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF? ( Mullangi, R; Mustafa, S; Pasha, K; Srinivas, NR; Venkatesh, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, F | 1 |
| Shimada, J | 1 |
| Mizumoto, H | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Nonaka, H | 1 |
| Ishii, A | 1 |
| Kawakita, T | 1 |
| Starr, MC | 1 |
| Charlton, JR | 3 |
| Guillet, R | 2 |
| Reidy, K | 1 |
| Tipple, TE | 1 |
| Jetton, JG | 1 |
| Kent, AL | 2 |
| Abitbol, CL | 1 |
| Ambalavanan, N | 1 |
| Mhanna, MJ | 1 |
| Askenazi, DJ | 2 |
| Selewski, DT | 2 |
| Harer, MW | 3 |
| Groves, AM | 1 |
| Johnston, CJ | 1 |
| Beutner, G | 1 |
| Dahlstrom, JE | 1 |
| Koina, M | 1 |
| O'Reilly, M | 1 |
| Marples, B | 1 |
| Porter, G | 1 |
| Brophy, PD | 1 |
| Hebert, JF | 1 |
| Eiwaz, MB | 1 |
| Nickerson, MN | 1 |
| Munhall, AC | 1 |
| Pai, AA | 1 |
| Groat, T | 1 |
| Andeen, NK | 1 |
| Hutchens, MP | 1 |
| Wolter, J | 1 |
| Grün, D | 1 |
| Otto, S | 1 |
| Boohaker, LJ | 1 |
| Carmody, JB | 3 |
| Griffin, RL | 1 |
| Swanson, JR | 2 |
| Aviles-Otero, N | 1 |
| Kumar, R | 1 |
| Khalsa, DD | 1 |
| Green, G | 1 |
| Campana, C | 1 |
| Griffin, PL | 1 |
| Simon, EL | 1 |
| Golcuk, Y | 1 |
| Ozsarac, M | 1 |
| Golcuk, B | 1 |
| Gunay, E | 1 |
| Puri, N | 1 |
| Mohey, V | 1 |
| Singh, M | 1 |
| Kaur, T | 1 |
| Pathak, D | 1 |
| Buttar, HS | 1 |
| Singh, AP | 1 |
| Denotti, AR | 1 |
| Schöffl, I | 1 |
| Kothmann, JF | 1 |
| Schöffl, V | 1 |
| Rupprecht, HD | 1 |
| Rupprecht, T | 1 |
| FENNELLY, JJ | 1 |
| LASKER, N | 1 |
| YOUNG, JV | 1 |
| HAYDON, GB | 1 |
| GRAY, CP | 1 |
| HECKER, SP | 1 |
| LEE, PR | 1 |
| Mustafa, S | 1 |
| Venkatesh, P | 1 |
| Pasha, K | 1 |
| Mullangi, R | 1 |
| Srinivas, NR | 1 |
| Kamijo, Y | 1 |
| Soma, K | 1 |
| Asari, Y | 1 |
| Ohwada, T | 1 |
| Favreau, JT | 1 |
| Ryu, ML | 1 |
| Braunstein, G | 1 |
| Orshansky, G | 1 |
| Park, SS | 1 |
| Coody, GL | 1 |
| Love, LA | 1 |
| Fong, TL | 1 |
| Wrenn, KD | 1 |
| Oschner, I | 1 |
| Arnold, L | 1 |
| Collins, C | 1 |
| Starmer, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates[NCT02443389] | 2,186 participants (Actual) | Observational [Patient Registry] | 2015-03-31 | Completed | |||
| Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for caffeine and Acute Kidney Failure
| Article | Year |
|---|---|
Advances in Neonatal Acute Kidney Injury.
Topics: Acute Kidney Injury; Biomarkers; Caffeine; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Infant, | 2021 |
Rhabdomyolysis induced by a caffeine overdose.
Topics: Acute Kidney Injury; Adult; Caffeine; Humans; Male; Peritoneal Dialysis; Rhabdomyolysis; Suicide, At | 1989 |
18 other studies available for caffeine and Acute Kidney Failure
| Article | Year |
|---|---|
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Cations, Monovalent; Diuretics; Male; Potassium; Radioligan | 1992 |
Effects of photobiomodulation and caffeine treatment on acute kidney injury in a hypoxic ischemic neonatal rat model.
Topics: Acute Kidney Injury; Albumins; Animals; Animals, Newborn; Biomarkers; Caffeine; Humans; Hypoxia-Isch | 2023 |
Legal Performance-enhancing Drugs Alter Course and Treatment of Rhabdomyolysis-induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Caffeine; Cilastatin; Glycerol; Humans; Ibuprofen; Mice; Performance-E | 2023 |
[Severe caffeine poisoning with rhabdomyolysis].
Topics: Acute Kidney Injury; Adult; Caffeine; Humans; Male; Renal Dialysis; Rhabdomyolysis; Suicide, Attempt | 2018 |
Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.
Topics: Acute Kidney Injury; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature, Disease | 2018 |
Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.
Topics: Acute Kidney Injury; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature, Disease | 2018 |
Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.
Topics: Acute Kidney Injury; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature, Disease | 2018 |
Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.
Topics: Acute Kidney Injury; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature, Disease | 2018 |
Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation.
Topics: Acute Kidney Injury; Age Factors; Caffeine; Enterocolitis, Necrotizing; Female; Gestational Age; Hum | 2019 |
Caffeine overdose resulting in severe rhabdomyolysis and acute renal failure.
Topics: Acute Kidney Injury; Adult; Caffeine; Central Nervous System Stimulants; Drug Overdose; Emergency Se | 2014 |
Caffeine-induced rhabdomyolysis.
Topics: Acute Kidney Injury; Caffeine; Central Nervous System Stimulants; Humans; Male; Rhabdomyolysis | 2014 |
Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
Topics: Acute Kidney Injury; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 | 2016 |
Caffeine Exposure and Risk of Acute Kidney Injury in a Retrospective Cohort of Very Low Birth Weight Neonates.
Topics: Acute Kidney Injury; Caffeine; Creatinine; Female; Humans; Infant, Newborn; Infant, Very Low Birth W | 2016 |
"Vodka energy": too much for the adolescent nephron?
Topics: Acute Kidney Injury; Adolescent; Alcoholic Beverages; Caffeine; Humans; Male; Nephrons; Taurine | 2011 |
ACUTE RENAL FAILURE FOLLOWING ACETOPHENETIDIN INGESTION.
Topics: Acidosis; Acute Kidney Injury; Aspirin; Caffeine; Diabetes Mellitus; Diabetic Ketoacidosis; Diagnosi | 1964 |
NEPHROPATHY ASSOCIATED WITH THE USE OF ANALGESIC MEDICATIONS.
Topics: Acute Kidney Injury; Amobarbital; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Antip | 1965 |
Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF?
Topics: Acute Kidney Injury; Adenosine A1 Receptor Antagonists; Animals; Caffeine; Drug Interactions; In Vit | 2006 |
Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia.
Topics: Acute Kidney Injury; Adult; Caffeine; Creatine Kinase; Delirium; Humans; Hyponatremia; Male; Rhabdom | 1999 |
Severe hepatotoxicity associated with the dietary supplement LipoKinetix.
Topics: Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Benzofurans; Benzopyrans; Caffe | 2002 |
Summary for patients. Liver failure associated with the dietary supplement LipoKinetix.
Topics: Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Benzofurans; Benzopyrans; Caffe | 2002 |
The short-term effects of analgesics on the kidney with special reference to acetylsalicylic acid.
Topics: Acetaminophen; Acute Kidney Injury; Administration, Oral; Animals; Aspirin; Caffeine; Dose-Response | 1973 |